J.D. Turner – författare

This monograph has grown out of the authors'' recent work directed toward solving a family of problems which arise in maneuvering modern spacecraft. The work ranges from fundamental developments in analytical dynamics and optimal control to a significant collection of example applications. The primary emphasis herein is upon the most central analytical and numerical methods for determining optimal rotational maneuvers of spacecraft. The authors focus especially upon the large angle nonlinear maneuvers, and also consider large rotational maneuvers of flexible vehicles with simultaneous vibration suppression/arrest. Each chapter includes a list of references.The book provides much new material which will be of great interest to practising professionals and advanced graduate students working in the general areas of spacecraft technology, applied mathematics, optimal control theory, and numerical optimization. Chapter 11 in particular presents new information that will be found widely useful for terminal control and tracking maneuvers.

Forest Trees of Australia is the essential reference for observing, identifying and obtaining information on the native trees in this country. It describes and illustrates over 300 of our most important indigenous trees, which have been carefully selected for their environmental significance, their importance to the timber industry, or their prominence in our landscape.This new and thoroughly revised edition has been fully updated throughout and includes treatments of 72 additional species. New maps and photographs show us a wonderfully diverse range of forests, from mangrove swamps, tropical regions and deserts, to alpine areas and majestic stands of temperate forests. A colour section illustrates some of the major forest types of Australia and bark from a diverse range of species.Forest Trees of Australia is an unsurpassed guide to identification for horticulturists, botanists, foresters, students, farmers, environmentalists and all those who are interested in our native trees.

Alzheimer''s Disease is a progressive neurodegenerative disorder of late life with devastating consequences for the afflicted and their carers and poses one of the major challenges to medical research. Until recently, little hope of effective therapies capable of slowing the disease process or preventing its occurrence was apparent. With recent advances in the genetics and molecular biology of the disease processes and the demonstration of the involvement of multiple aetiological factors, however, real chances are now appearing for the identification of preventive drugs. In this discussion, experts from disciplines ranging from molecular genetics to the clinic provide review and novel data concerning the aetiology of AD and the establishment of drugfinding screening methods.

Alzheimer's Disease is a progressive neurodegenerative disorder of late life with devastating consequences for the afflicted and their carers and poses one of the major challenges to medical research. Until recently, little hope of effective therapies capable of slowing the disease process or preventing its occurrence was apparent. With recent advances in the genetics and molecular biology of the disease processes and the demonstration of the involvement of multiple aetiological factors, however, real chances are now appearing for the identification of preventive drugs. In this discussion, experts from disciplines ranging from molecular genetics to the clinic provide review and novel data concerning the aetiology of AD and the establishment of drugfinding screening methods.

The use of cells for the treatment of a variety of diseases is no longer a dream. Today, blood transfusion, bone marrow transplantation, the use of ex vivo cultured skin in wound healing, and peripheral stern cell transplantation, including the ex vivo expansion of hematopoietic stern cells after high-dose chemo/radiation therapy, are routine. This high standard of knowledge and skills in cell transplantation might also re­ sult in tackling hitherto untreatable diseases. Organ transplantation is presently the only life-saving treatment for a variety of conditions. Important findings in cell and molecular biol­ ogy, the identification of hematopoietic, mesenchymal and neuronal stern cells, together with breakthroughs in the methodology for isolat­ ing, purifying, expanding, and storing human cells could make cellular therapy an alternative to organ transplantation in certain diseases within the next decade. Placental blood may be the source of choice in isolating naive progenitor cells for allogeneic transplantation. Immunotherapy is the most hopeful strategy to date for the treat­ ment of tumors resistant to chemotherapy, radiation therapy, or hor­ mone therapy. It includes the use of tumor-infiltrating lymphocytes, ex vivo activated memory T lymphocytes, and cell-based vaccines.

The use of cells for the treatment of a variety of diseases is no longer a dream. Today, blood transfusion, bone marrow transplantation, the use of ex vivo cultured skin in wound healing, and peripheral stern cell transplantation, including the ex vivo expansion of hematopoietic stern cells after high-dose chemo/radiation therapy, are routine. This high standard of knowledge and skills in cell transplantation might also re­ sult in tackling hitherto untreatable diseases. Organ transplantation is presently the only life-saving treatment for a variety of conditions. Important findings in cell and molecular biol­ ogy, the identification of hematopoietic, mesenchymal and neuronal stern cells, together with breakthroughs in the methodology for isolat­ ing, purifying, expanding, and storing human cells could make cellular therapy an alternative to organ transplantation in certain diseases within the next decade. Placental blood may be the source of choice in isolating naive progenitor cells for allogeneic transplantation. Immunotherapy is the most hopeful strategy to date for the treat­ ment of tumors resistant to chemotherapy, radiation therapy, or hor­ mone therapy. It includes the use of tumor-infiltrating lymphocytes, ex vivo activated memory T lymphocytes, and cell-based vaccines.